Skip to main content
News Icon

New Speaker and Executive Board Member

Prof. Joachim L. Schultze from the LIMES Institute Bonn resigned in his position as speaker and member of the executive board of the Cluster of Excellence.

We wish him all the best for his future tasks in the field of immunology and we are more then happy that he supports the Cluster of Excellence ImmunoSensation as a member of the steering committe and valuable group leader.

As a succesor for the speaker position Prof. Waldemar Kolanus and as succesor for the executive board member position Prof. Elvira Mass, both from the LIMES Institute in Bonn, will replace Prof. Joachim L. Schultze.

Welcome Prof. Kolanus and Prof. Mass in your new roles in the Cluster of Excellence ImmunoSensation2.

Related news

Prof. Dr. Oliver Brüstle

Focus

Welcoming Oliver Brüstle to ImmunoSensation

—We are delighted to welcome Prof. Dr. Oliver Brüstle, head of the Institute of Reconstructive Neurobiology at the University Hospital Bonn, to the Cluster of Excellence ImmunoSensation2. Oliver Brüstle is a leading expert in stem cell research and regenerative medicine, bringing an exciting new dimension to the Cluster's interdisciplinary focus on immunity in health and disease.
View entry
Bone2Gene Funding Peter Krawitz

Honors & Funding

“Bone2Gene” Secures €1 Million Grant

—The “Bone2Gene” project of researchers from the University of Bonn and University Hospital Bonn has been awarded funding worth €1,000,000 as part of the Federal Ministry of Education and Research’s GO-Bio initial program. The money is now enabling the team arround ImmunoSensation Member Prof. Peter Krawitz, to progress to the feasibility phase and get its product ready for market launch. “Bone2Gene“ is using artificial intelligence (AI) to make genetic bone conditions known as skeletal dysplasia easier to spot and diagnose.
View entry
Basmanav

Publication

Inflammatory diseases influence the course of hair loss

—Asthma, atopic dermatitis or Hashimoto's thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also known as alopecia areata (AA). In patients with three atopic diseases, namely atopic dermatitis, asthma and rhinitis, the average age of onset of AA is about ten years earlier than in patients without chronic inflammatory comorbidities. This has now been established by researchers from Bonn in a large cohort study of affected patients. Their results have now been published in the journal "Allergy".
View entry

Back to the news overview